SEER Inquiry System - Question 20031210 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 05/29/2026 5:20 PM

Question 20031210

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

#1: SEER Program Code Man, 3rd Ed, 140. January 1998

#2: 2004 SEER Manual, 200-201

Question:

Other Cancer-Directed Therapy--Hematopoietic, NOS: Is there a hierarchy for selecting which code to use when a patient receives more than one type of "other treatment"? See Description.

Discussion:

Patient was diagnosed with Myelodysplastic Syndrome, probably refractory cytopenia with multilineage dysplasia. Good candidate for investigational studies for transfusion-dependent patients. Patient was enrolled in a high dose vitamin D study. Patient also received transfusions.

Answer:

SEER has not established a hierarchy of the codes listed under Other Treatment. If the patient receives more than one type of other treatment as the first course of treatment, assign the code that provides the most information about how the patient was treated and use the remarks fields to explain.

Code Other Treatment for the case example above as 2 [Other experimental therapy]. Use the remarks fields to describe the transfusions and vitamin D therapy.

Cancer Site Category:

N/A

Data Item Category:

Other therapy

Other Category:

N/A

Year:

2003